Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Computerized Strengthening d: A Survey of \Upgrading Efficiency\ Programming Application - 2The ‘Stranger Things’ finale, explained: What happens to Vecna? And why was a key character’s fate left unknown?
- 36 Web-based Staple Help You Can Trust
- 4Russia Establishing Long-Range Drone Bases In Belarus, Warns Ukraine
- 5Flu activity rises sharply across US with 7.5 million cases, CDC data shows
- The Main 20 Photography Instagram Records to Follow
- Pick Your #1 breakfast food
- Vote In favor of Your Favored Shades
- Israel’s mixed messaging on Christmas draws controversy
- South African army arrive in crime hotspots to help tackle gangs
- Peloton recalls more than 800,000 bikes after broken seat posts injure users
- Countdown to Artemis II: What to know about NASA's moon mission
- Bring tissues and skip the mascara: The movie that's making theater-goers sob uncontrollaby
- Instructions to Warmly greet Discretion and Thoughtfulness
